EFC Congress 2024
Scientific Programme
The Congress is going to be held in Central European Summer Time zone. To convert to your time zone, please click here.
DIFFICULT CASES IN COLPOSCOPY
Chair: Deirdre Lyons (GB), Vesna Kesic (RS)
09:00 – 10:30 Pregnancy
09:00 – 09:30 Pregnancy Theory
Speaker: Andrea Ciavattini (IT), Mihaela Grigore (RO)
09:30 – 09:40 Pregnancy Case 1
Speaker: Andrea Ciavattini (IT), Mihaela Grigore (RO)
09:40 – 09:50 Pregnancy Case 2
Speaker: Andrea Ciavattini (IT), Mihaela Grigore (RO)
09:50 – 10:00 Pregnancy Case 3
Speaker: Andrea Ciavattini (IT), Mihaela Grigore (RO)
10:00 – 10:10 Pregnancy Case 4
Speaker: Andrea Ciavattini (IT), Mihaela Grigore (RO)
10:10 – 10:20 Pregnancy Case 5
Speaker: Andrea Ciavattini (IT), Mihaela Grigore (RO)
10:20 – 10:30 Pregnancy Case 6
Speaker: Andrea Ciavattini (IT), Mihaela Grigore (RO)
10:30 – 11:00 Coffee break
11:00 – 12:30 Glandular pathology
11:00 – 11:30 Glandular pathology Theory
Speaker: Grainne Flannelly (IE), Deirdre Lyons (GB)
11:30 – 11:40 Glandular pathology Case 1
Speaker: Grainne Flannelly (IE), Deirdre Lyons (GB)
11:40 – 11:50 Glandular pathology Case 2
Speaker: Grainne Flannelly (IE), Deirdre Lyons (GB)
11:50 – 12:00 Glandular pathology Case 3
Speaker: Grainne Flannelly (IE), Deirdre Lyons (GB)
12:00 – 12:10 Glandular pathology Case 4
Speaker: Grainne Flannelly (IE), Deirdre Lyons (GB)
12:10 – 12:20 Glandular pathology Case 5
Speaker: Grainne Flannelly (IE), Deirdre Lyons (GB)
12:20 – 12:30 Glandular pathology Case 6
Speaker: Grainne Flannelly (IE), Deirdre Lyons (GB)
12:30 – 13:30 Lunch break
13:30 – 15:00 VIN & VaIN
13:30 – 14:00 VIN& VaIN Theory
Speaker: Vesna Kesic (SRB) Xavier Carcopino (FR)
14:00 – 14:10 VIN& VaIN Case 1
Speaker: Vesna Kesic (SRB) Xavier Carcopino (FR)
14:10 – 14:20 VIN& VaIN Case 2
Speaker: Vesna Kesic (SRB) Xavier Carcopino (FR)
14:20 – 14:30 VIN& VaIN Case 3
Speaker: Vesna Kesic (SRB) Xavier Carcopino (FR)
14:30 – 14:40 VIN& VaIN Case 4
Speaker: Vesna Kesic (SRB) Xavier Carcopino (FR)
14:40 – 14:50 VIN& VaIN Case 5
Speaker: Vesna Kesic (SRB) Xavier Carcopino (FR)
14:50 – 15:00 VIN& VaIN Case 6
Speaker: Vesna Kesic (SRB) Xavier Carcopino (FR)
15:00 – 15:30 Coffee break
15:30 – 17:00 Anal and multizonal disease
15:30 – 16:00 Anal and multizonal disease Theory
Speaker: Deirdre Lyons (GB), Maggie Cruickshank (GB)
16:00 – 16:10 Anal and multizonal disease Case 1
Speaker: Deirdre Lyons (GB), Maggie Cruickshank (GB)
16:10 – 16:20 Anal and multizonal disease Case 2
Speaker: Deirdre Lyons (GB), Maggie Cruickshank (GB)
16:20 – 16:30 Anal and multizonal disease Case 3
Speaker: Deirdre Lyons (GB), Maggie Cruickshank (GB)
16:30 – 16:40 Anal and multizonal disease Case 4
Speaker: Deirdre Lyons (GB), Maggie Cruickshank (GB)
16:40 – 16:50 Anal and multizonal disease Case 5
Speaker: Deirdre Lyons (GB), Maggie Cruickshank (GB)
16:50 – 17:00 Anal and multizonal disease Case 6
Speaker: Deirdre Lyons (GB), Maggie Cruickshank (GB)
BASIC COLPOSCOPY COURSE
Chair: Maggie Cruickshank (GB), Jana Žodžika (LV)
09:00 – 10:30 Colposcopic principles
09:00 – 09:10 Introduction
09:10 – 09:30 Basics of Human Papilloma Virus cervical infection
Speaker: Maggie Cruickshank (GB)
09:30 – 09:50 Colposcopy exam of the normal cervix (TZ, SCJ, metaplasia)
Speaker: Maria Castro (ES)
09:50 – 10:10 Colposcopic nomenclature and useful scoring systems
Speaker: Jana Žodžika (LV)
10:10 – 10:30 Discussions
10:30 – 11:00 Coffee break
11:00 – 12:30 Colposcopic diagnosis
11:00 – 11:30 Management principles of the cervical SIL
and European guidelines
Speaker: Maria Castro (ES)
11:30 – 12:30 Interactive case and discussion
Speaker: Jana Žodžika (LV), Annu Heinonen (FI), Maria Castro (ES), Maggie Cruickshank (GB)
12:30 – 13:30 Lunch break
13:30 – 15:00 Colposcopic management
13:30 – 13:50 Follow up after treatment
Speaker: Annu Heinonen (FI)
13:50 – 14:10 Morbidity and safety of treatments
Speaker: Jana Žodžika (LV)
14:10 – 14:30 Basics of Cervical Cytology and Histology of Normal and Abnormal Cervical Epithelium
Speaker: Christine Bergeron (FR)
14:30 – 15:00 Interactive case and discussion
Speaker: Jana Žodžika (LV), Christine Bergeron (FR), Annu Heinonen (FI), Maria Castro (ES), Maggie Cruickshank (GB)
15:00 – 15:30 Coffee break
15:30 – 17:00 Interactive session “How to set the colposcope?”
15:30 – 15:50 Colposcope: the device and how to use it?
Speaker: Maria Castro (ES)
15:50 – 17:00 Colposcopy setting – 3 stations with 3 colposcopes
Speaker: Annu Heinonen (FI),Maria Castro (ES),Jana Žodžika (LV)
Congress
From Thursday September 19 to Saturday September 21
Live streaming available
09:00 – 09:10 Opening session
Maggie Cruickshank (GB), Jana Žodžika (LV) and Lasma Lidaka (LV)
09:10 – 09:20 In Memorium Charles Redman
09:20 – 10:50 Working towards eliminating cervical cancer
Current knowledge on HPV natural history and screening: part I
Chairs: Laura Kotaniemi (FI), Anne Hammer (DK)
- Current evidence for HPV natural history and latency – Speaker: John Doorbar (GB)
- Clinical implications of HPV latency – Speaker: Anne Hammer (DK)
- The role of microbiome on HPV infection and SIL – Speaker: Olga Plisko (LV)
- Triage of HPV-positive patients – Speaker: Marc Arbyn (BE)
10:50 – 11:20 Coffee break & Selected Free Communications
Chairs: Kristina Jariene, Karoliina Louvanto
- Distribution of intraepithelial lymphocytes and macrophages in cervical microenvironment during the progression of cervical intraepithelial neoplasia – Speaker: Ketevan Manjgaladze
- Can implementing swede score at conization increase the proportion of coni with negative resection margins? preliminary data – Speaker: Astrid Bakke Orvik
- Adequacy of excisional treatment for cervical precancer in denmark – Speaker: Ane-Kersti Skaarup Knudsen
- internal audit of the center of expert colposcopy. is it possible to meet the ecf criteria? – Speaker: Vladimir Dvorak jr.
11:20 – 12:50 Working towards eliminating cervical cancer
Current knowledge on HPV natural history and screening: part II
Chairs: Maggie Cruickshank (GB) and Jana Žodžika (LV)
- Do we need co-testing ? – Speaker: Olaf Reich (AT) & Christine Bergeron (FR)
- Is high-grade squamous intraepithelial lesion risk-based management the future of cervical cancer screening? – Speaker: Maciej Mazurec (PO)
- Screening for cervical cancer in older women – Speaker: Anne Hammer (DK)
- Self-sampling in HPV-based screening programmes – Speaker: Kristina Elfgren (SE)
12:50 – 14:35 Free time
14:35 – 16:00 HPV vaccination: moving towards cervical cancer eradication
Chairs: Pekka Nieminen (FI), DaceRezeberga (LV)
- Status of HPV vaccination in Europe – results of EU4Joint Action PERCH – Speaker: Marc Arbyn (BE)
- Impact of vaccination on screening – Speaker: Simopekka Vänskä (FI)
- Impact of vaccination on colposcopy – Speaker: Maggie Cruickshank (GB)
- Vaccination after treatment of SIL? – Speaker: Pekka Nieminen (FI)
- Vaccination after treatment: NOVEL study – preliminary results – Speaker: Pekka Nieminen (FI)
16:00 – 16:30 Coffee break & Selected Free Communications
Chairs: Eva-Maria Niine-Roolaht, Tamar Alibegashvili
- Parity as a predictive factor of cervical length regeneration after large loop excision of the transformation zone – Speaker: Laura Lūse
- The role of colposcopy in identifying precancerous changes in the cervix – Speaker: Nargiz Gurbatova
- Evaluation of C-ARG and Equalis’ national External Quality Assurance (EQA) scheme of colposcopy examinations 2024 – Speaker: Hanna Milerad
- The Risk Factors of Cervical Squamous Intraepithelial Lesions Among Women Attending Colposcopy Clinic – Speaker: Natalija Berza
16:30 – 17:30 Communication with patients and social media
Chairs: Grainne Flannelly (IRL), Ameli Trope (NO)
- New paradigm of social media – Speaker: Grainne Flannelly (IE)
- How to inform patients and which information should we provide about HPV infection and vaccination – Speaker: Laura Kotaniemi (FI)
- A Patient voice – Speaker: Johanna Vierikko (FI)
17:30 – 18:30 Selected best oral presentations
Chairs: Olga Plisko (LV), Maria Castro (ES)
- Abstract presentation N1 : Screening behavior after HSIL/AIS and the risk of invasive cervical and vaginal cancer: A nationwide cohort study 1999-2018 Speaker : Hanna Milerad
- Abstract presentation N2 : Women’s reasoning and experience in the cervical cancer screening program when offered a self-sampling hpv-test: a qualitative content analysis Speaker : Caroline Hellsten
- Abstract presentation N3 : Comparison of cytological and hpv-based screening within population-based screening program in finland Speaker : Iiris Turunen
- Abstract presentation N4 : Reproducibility of colposcopy quality indicators – a survey among members of the european federation for colposcopy Speaker : Tina Hovgaard Randrup
- Abstract presentation N5 : Routine program audit of cervical cancer to identify remaining risks and guide elimination efforts Speaker : Cecilia Kärrberg
- Abstract presentation N6 : DNA methylation for risk-stratification of screen-positive women with a TZ3 Speaker : Anne Hammer
08:30 – 09:00 Selected best oral presentations
Chairs: Anne Hammer (DK), Kristina Jariene (LT)
- Abstract presentation N7 : The effect of the covid-19 pandemic on colposcopy services and practice: a systematic review and meta-analysis Speaker : Giovanni Delli Carpini
- Abstract presentation N8 : Understanding Women’s Values in Managing Human Papillomavirus (HPV) Speaker : Alice McGee
- Abstract presentation N9 : Mapping the spread: spatial analysis of hpv infection and contributing factors Speaker : Rita Sousa
09:00 – 10:45 Optimal management of cervical intraepithelial lesions
Chairs: Illka Kalliala (FI), Kristīne Pčolkina (LV)
- Management of persistent HPV and low-grade lesions – Speaker: Andrea Ciavattini (IT)
- Clinical management of CIN2 across countries – Speaker: Karolina Aro (FI)
- Risk of persistency and progression of CIN2 – Speaker: Kathrine Dyhr Lycke (DK)
- Risk stratifications of CIN 2 for clinical management – Speaker: Karoliina Louvanto (FI)
- Optimal treatment strategies of adenocarcinoma in situ – Speaker: Xavier Carcopino (FR)
10:45 – 11:15 Coffee break & Selected Free Communications
Chairs: Dace Rezeberga & Mihaela Grigore
- Recognition of reserved cells and their proliferative pattern at clear margins of leep sample as possible marker of high risk of cin2+ recurrences – Speaker: Iryna Muryzina
- Efficacy of intensive regimen of a multi-ingredient coriolus versicolor-based vaginal gel in increasing hpv clearance: results from the paloma clinical trial – Speaker: Luis Serrano
- Efficacy of a multi-ingredient coriolus versicolor-based vaginal gel on high-risk hpv clearance: preliminary results from the paloma 2 clinical trial – Speaker: Patricia Sanmartin Salinas
- Efficacy of intensive regimen of a multi-ingredient coriolus versicolor-based vaginal gel (papilocare®) in hr-hpv clearance: preliminary pooled results from the paloma 1 and paloma 2 clinical trials – Speaker: Luis Serrano
- Effect of a multi-ingredient coriolus versicolor-based vaginal gel on hpv 16/18 clearance: preliminary results from the papilocan clinical trial – Speaker: Patricia Sanmartin Salinas
- Evaluating the efficacy of coriolus versicolor-based vaginal gel in conservative management of cin2 lesions: an observational study – Speaker: Nadia Nassar
11:15 – 12:45 Challenges in colposcopy
Chairs: Xavier Carcopino (FR), Kristina Jariene (LT)
- Management of women with type 3 TZ – Speaker: Jean Luc Mergui (FR)
- Colposcopy of pregnant women – Speaker: Wojciech Kolawa (PO)
- Screening and management of immunocompromised women – Speaker: Ruud Bekkers (NL)
- Prospects of eliminating cervical cancer in Ukraine – Speaker: Natalya Volodko (UA)
12:45 – 14:00 Free time
14:00 – 15:30 Ensuring standards and quality assurance in women in Europe: colposcopy standards
Chairs: Maggie Cruickshank (GB) and Robert Jach (PO)
- Challenging colposcopy cases: applying EFC/ESGO European consensus statement on expert colposcopy – Speaker: Maggie Cruickshank (GB)
- Cervical cancer screening in Europe: quality assurance and organsiation of programmes in 2024 – Speaker: Miriam Elfström (SE)
- Ambitions for quality assurance in Hungary – Speaker: Robert Koiss (HU)
- Feasibility of collecting and comparing quality indicators on colposcopy – an update from the EFC Quality and standard group – Speaker: Anne Hammer (DK)
15:30 – 16:00 Coffee break & Selected Free Communications
Chairs: Kristīne Pčolkina & Natalya Volodko
- Cervical cancer screening in a health centre in lisbon – a retrospective observational study – Speaker: Inês Cordeiro
- Analysis of screening history of cervical cancer cases in latvia – Speaker: Elvita Penka
- Prevention of cervical cancer in latvia – Speaker: Gunta Lazdane
- Comparative analysis of pap-test and histological examination in various degrees of cervical intraepithelial neoplasia (cin) – Speaker: Yelena Dissyukeyva
- HPV vaccination and recurrence of cervical intraepithelial neoplasia: insights from a retrospective analysis – Speaker: Marta Almeida
16:00 – 17:30 Ensuring the prevention of cervical cancer: reducing the risk for women post-treatment
Chairs: Xavier Carcopino(FR), Maria Castro (ES)
- Reasons of recurrent and residual disease after cervical SIL treatment – Speaker: Evangelos Paraskevaidis (GR)
- Post-treatment follow-up of cervical SIL and adenocarcinoma in situ – Speaker: Maggiorino Barbero (IT)
- Follow up after VIN and VaIN treatment – Speaker: Vesna Kesic (SRB)
17:30 – 18:00 Selected best oral presentations
Chairs: Eva-Maria Niine-Roolaht (EE), Tamar Alibegashvili (GE)
- Abstract presentation N10 : Does active surveillance for cin2 reduce the risk of preterm birth? a danish registry-based cohort study Speaker : Kathrine Dyhr Lycke
- Abstract presentation N11 : HPV E4/p16INK4a immunohistochemistry for the prediction of CIN2 regression – a historical cohort study Speaker : Anne Hammer
- Abstract presentation N12 : Risk of anogenital precancer and cancer in women undergoing active surveillance for cin2 – a population-based cohort study Speaker : Kathrine Dyhr Lycke
08:30 – 09:00 Selected best oral presentations
Chairs: Jana Žodžika (LV), Annu Heinonen (FI)
- Abstract presentation N13 : Clinical management of postmenopausal women attending colposcopy after an abnormal cervical cancer screening test – a survey across EFC member countries Speaker : Lotte Krog Eriksen
- Abstract presentation N14 : Probability and predictive factors of the absence of high-grade intraepithelial lesion on excision specimen following histological diagnosis of high-grade intraepithelial lesion Speaker : Sophia Assirlikian
- Abstract presentation N15 : Can swedescore improve the diagnostic accuracy of cervical cancer and precancer? Speaker : Ane-Kersti Skaarup Knudsen
09:00 – 10:15 Cervical pre/cancer and reproductive outcomes
Chairs: Mihaela Grigore (RO), Maria Kyrgiou (GB)
- Fertility sparing treatment in cervical cancer – selection of candidates and management ESGO/ESTRO/ESP Update 2023 – Speaker: Robert Jach (PO)
- HPV infection and fertility – Speaker: Ilkka Kalliala (FI)
- Optimal decision making in management of SIL – Speaker: Maria Kyrgiou (GB)
10:15 – 10:45 Coffee break & Selected Free Communications
Chairs: Olga Plisko & Ameli Trope
- Management of CIN 2 – review of outcomes – Speaker: Deirdre Lyons
- Gastric type endocervical adenocarcinoma with bilateral metastases to ovaries: a case report – Speaker: Emeri Laas
- Risk of gestational diabetes mellitus following management for cervical intraepithelial neoplasia grade 2 – Speaker: Lotte Krog Eriksen
- Pelvic vessel embolization: life saving procedure for vaginal bleeding in advanced cervical cancer –Speaker: Lubova Lapidus
10:45 – 12:45 Multidisciplinary team meetings in colposcopy
Chairs: Pekka Nieminen (FI), Christine Bergeron (FR)
- How to organize an MDT in colposcopy clinic – Speaker: Pekka Nieminen (FI)
- Multidisciplinary team meeting in colposcopy Case 1 – Speaker: Kristina Jariene (LT)
- Multidisciplinary team meeting in colposcopy Case 2 – Speaker: Eva-Maria Niine-Roolaht (EE)
- Multidisciplinary team meeting in colposcopy Case 3 – Speaker: Melanie Henes (DE)
- Multidisciplinary team meeting in colposcopy Case 4 – Speaker: Kristine Pcolkina (LV)
- Report of recipient of the Emmanuel Diakomanolis EFC Colposcopy prizes 2022: Experience on quality assurance system in UK – Speaker: Iryna Muryzina (UA)
- Report of recipient of the Emmanuel Diakomanolis EFC Colposcopy prizes 2022: Experience on training and education programme in colposcopy in Finland – Speaker: Luka Roškar (SI)
12:45 – 13:15 Closing remarks & Awards Ceremony
Tickets
Register for EFC congress 2024
10th European Federation For Colposcopy Congress
“Cervical cancer prevention and colposcopy”
Get In Touch
Contact us if you require more information or have any question.